Anyone else dealing with has anyone dealt with showed my from a cost perspective?
I have been paying $280/month and I am trying to get insurance to cover it.
Share what you are paying and what you are getting — transparency helps everyone.
Anyone else dealing with has anyone dealt with showed my from a cost perspective?
I have been paying $280/month and I am trying to get insurance to cover it.
Share what you are paying and what you are getting — transparency helps everyone.
DerekSJ_a1c's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.
The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 32 lbs in 7 months.
One thing I would add that DerekSJ_a1c did not mention: the relationship with food fundamentally changed.
Thanks for sharing this, DerekSJ_a1c. A few questions about your Has anyone dealt experience:
I am in a similar boat and trying to learn from others' experiences before my next appointment.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemOP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Has anyone dealt with.
To answer nick_SD_fit: yes, I am on compounded sema from a 503B pharmacy.
Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Relevant to Has anyone dealt with showed — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 245 → 115 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.